Inhibition of CMTM4 Sensitizes Cholangiocarcinoma and Hepatocellular Carcinoma to T Cell-Mediated Antitumor Immunity Through PD-L1.
Hepatol Commun
; 6(1): 178-193, 2022 01.
Article
in En
| MEDLINE
| ID: mdl-34558800
Full text:
1
Database:
MEDLINE
Main subject:
Cholangiocarcinoma
/
Carcinoma, Hepatocellular
/
Programmed Cell Death 1 Receptor
/
MARVEL Domain-Containing Proteins
/
Liver Neoplasms
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Hepatol Commun
Year:
2022
Type:
Article
Affiliation country:
Hong Kong